相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Breast Cancer Molecular Subtype Prediction by Mammographic Radiomic Features
Wenjuan Ma et al.
ACADEMIC RADIOLOGY (2019)
Breast cancer Ki67 expression prediction by DCE-MRI radiomics features
W. Ma et al.
CLINICAL RADIOLOGY (2018)
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions
Margarita Kirienko et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Radiomics and radiogenomics for precision radiotherapy
Jia Wu et al.
JOURNAL OF RADIATION RESEARCH (2018)
Radiomics and radiogenomics in lung cancer: A review for the clinician
Rajat Thawani et al.
LUNG CANCER (2018)
Comprehensive Computed Tomography Radiomics Analysis of Lung Adenocarcinoma for Prognostication
Geewon Lee et al.
ONCOLOGIST (2018)
Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy
Jia Wu et al.
RADIOLOGY (2018)
Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy
Anastasia Oikonomou et al.
SCIENTIFIC REPORTS (2018)
Exploration of resistance mechanisms for epidermal growth factor receptor-tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next-generation sequencing
Eiji Iwama et al.
CANCER SCIENCE (2018)
Magnetic resonance imaging and molecular features associated with tumor- infiltrating lymphocytes in breast cancer
Jia Wu et al.
BREAST CANCER RESEARCH (2018)
Reliability of PET/CT Shape and Heterogeneity Features in Functional and Morphologic Components of Non-Small Cell Lung Cancer Tumors: A Repeatability Analysis in a Prospective Multicenter Cohort
Marie-Charlotte Desseroit et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non-Small Cell Lung Cancer
Stephen S. F. Yip et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Radiomics in PET/CT: More Than Meets the Eye?
Mathieu Hatt et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
The impact of image reconstruction settings on 18F-FDG PET radiomic features: multi-scanner phantom and patient studies
Isaac Shiri et al.
EUROPEAN RADIOLOGY (2017)
Identifying Relations Between Imaging Phenotypes and Molecular Subtypes of Breast Cancer: Model Discovery and External Validation
Jia Wu et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2017)
Clinical utility of texture analysis of 18F-FDG PET/CT in patients with Stage I lung cancer treated with stereotactic body radiotherapy
Kazuya Takeda et al.
JOURNAL OF RADIATION RESEARCH (2017)
Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic 18F Fluorodeoxyglucose PET
Tineke W. H. Meijer et al.
RADIOLOGY (2017)
The role of metabolic tumor volume (MTV) measured by [18F] FDG PET/CT in predicting EGFR gene mutation status in non-small cell lung cancer
Ao Liu et al.
ONCOTARGET (2017)
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology
M. Sollini et al.
SCIENTIFIC REPORTS (2017)
Texture-based classification of different single liver lesion based on SPAIR T2W MRI images
Zhenjiang Li et al.
BMC MEDICAL IMAGING (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer
Emmanuel Rios Velazquez et al.
CANCER RESEARCH (2017)
Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer
Arthur Cho et al.
BMC CANCER (2016)
EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape
Seung-Oe Lim et al.
CANCER RESEARCH (2016)
Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas
Ying Liu et al.
CLINICAL LUNG CANCER (2016)
Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy
Jia Wu et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2016)
Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation
Floris H. P. van Velden et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of 18F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis
Jia Wu et al.
RADIOLOGY (2016)
Tumor heterogeneity on 18F-FDG-PET/CT for response monitoring in non-small cell lung cancer treated with erlotinib
Matthijs H. van Gool et al.
Journal of Thoracic Disease (2016)
Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer
Viviana De Rosa et al.
CLINICAL CANCER RESEARCH (2015)
Total Lesion Glycolysis Determined per RECIST 1.1 Criteria Predicts Survival in EGFR Mutation-Negative Patients With Advanced Lung Adenocarcinoma
Tsung-Ying Ho et al.
CLINICAL NUCLEAR MEDICINE (2015)
Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non-Small-Cell Lung Cancer with Activating EGFR Mutation
Bhumsuk Keam et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Targeting EGFR in lung cancer: Lessons learned and future perspectives
Conor E. Steuer et al.
MOLECULAR ASPECTS OF MEDICINE (2015)
PET in the management of locally advanced and metastatic NSCLC
Willem Grootjans et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer
Pasi A. Jaenne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung Cancer
Erin M. Tricker et al.
CANCER DISCOVERY (2015)
Value of 18F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma
Kai-Hsiung Ko et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach (vol 5, pg 4006, 2014)
Hugo J. W. L. Aerts et al.
NATURE COMMUNICATIONS (2014)
Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis
Sugama Chicklore et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples
Gillian Ellison et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma
Paul M. Putora et al.
RESPIROLOGY (2013)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
Early [F-18]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung
Ryo Takahashi et al.
CLINICAL CANCER RESEARCH (2012)
Epidermal Growth Factor Receptor (EGFR) Signaling and Covalent EGFR Inhibition in Lung Cancer
Johannes M. Heuckmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Correlation Between 18F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Mutations in Advanced Lung Cancer
Yun-Jung Choi et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
18F-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
Matthias R. Benz et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Non-small-cell lung cancer
Peter Goldstraw et al.
LANCET (2011)
Evaluation of a 3D local multiresolution algorithm for the correction of partial volume effects in positron emission tomography
Adrien Le Pogam et al.
MEDICAL PHYSICS (2011)
Role of F-18-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
Raymond H. Mak et al.
ONCOLOGIST (2011)
Diagnostic value of 18F-FDG PET/CT and dedicated bone imaging in childhood sarcoma
Franziska Walter et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Measurement of Regional Specific Lung Volume Change Using Respiratory-Gated PET of Inhaled N-13-Nitrogen
Tyler J. Wellman et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Is F-18-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non-Small Cell Lung Cancer?
Tjeerd S. Aukema et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
F-18-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: A single-institution retrospective analysis
Im Il Na et al.
LUNG CANCER (2010)
Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma
Chun-Ta Huang et al.
MEDICAL ONCOLOGY (2010)
Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells
Y. Gan et al.
ONCOGENE (2010)
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Jihye Yun et al.
SCIENCE (2009)
Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors
Pasi A. Jaenne et al.
CLINICAL CANCER RESEARCH (2006)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Akt stimulates aerobic glycolysis in cancer cells
RL Elstrom et al.
CANCER RESEARCH (2004)
分享论文
